Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2021. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4550512014 | Tepotinib only product in oral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 4550513016 | Product containing only tepotinib in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only tepotinib in oral dose form (medicinal product form) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only tepotinib in oral dose form (medicinal product form) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only tepotinib in oral dose form (medicinal product form) | Is a | Product containing tepotinib in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only tepotinib in oral dose form (medicinal product form) | Has active ingredient | Tepotinib | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing only tepotinib in oral dose form (medicinal product form) | Is a | Tepotinib | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely tepotinib (as tepotinib hydrochloride) 225 milligram/1 each conventional release oral tablet (clinical drug) | Is a | True | Product containing only tepotinib in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR